Use of anti-androgenic 5α-reductase inhibitors and risk of oesophageal and gastric cancer by histological type and anatomical sub-site.

Sirus RabbaniGiola SantoniJesper LagergrenShao-Hua Xie

Published in: British journal of cancer (2022)

Users of 5-ARIs may have a decreased risk of developing oesophageal or cardia adenocarcinoma among those obese or diabetic, and a decreased risk of oesophageal squamous cell carcinoma.

Keyphrases

squamous cell carcinoma
type diabetes
locally advanced
metabolic syndrome
adipose tissue
weight loss
obese patients
rectal cancer
cone beam computed tomography